While 25-hydroxyvitamin D 3 3-O-sulfate is known to be present in circulation, how it is generated in the body remains unclear. This study aimed to investigate its sulfation in major human organs and to unveil the responsible cytosolic sulfotransferases (SULTs). Of the vitamin D 3 -related compounds tested, 25-hydroxyvitamin D 3 and 7-dehydrocholesterol are preferentially sulfated by human organ cytosols. Among the 13 human SULTs, SULT2A1 shows sulfating activity toward all vitamin D 3 -related compounds, whereas SULT1A1 and SULT2B1a/SULT2B1b show sulfating activity exclusively for, respectively, calcitriol and 7-dehydrocholesterol. These findings suggest that the metabolic pathway leading to the formation of 25-hydroxyvitamin D 3 3-O-sulfate may be mediated by the sulfation of 25-hydroxyvitamin D 3 or by the conversion of 7-dehydrocholesterol-3-O-sulfate in the skin.
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Keywords: 7-dehydrocholesterol; cytosolic sulfotransferase; sulfation; SULT2A1; SULT2B1; vitamin D 3 Vitamin D 3 is known to play an essential role in calcium and bone homeostasis [1] [2] [3] . An accumulating body of evidence indicates that vitamin D 3 deficiency is associated with diabetes mellitus as well as cardiovascular and kidney diseases, suggesting the involvement of vitamin D 3 in a myriad of biological events [3] [4] [5] . Although vitamin D 3 is generally known as a vitamin, it can actually be generated in vivo from 7-dehydrocholesterol. Studies have shown that 7-dehydrocholesterol can be converted to previtamin D 3 in the skin via UV irradiation by sunlight, followed by thermal isomerization to form vitamin D 3 [1, 3, 5] . Vitamin D 3 has been shown to be metabolized in the liver to form 25-hydroxyvitamin D 3 ) under the action of 25-hydroxylase (CYP2R1). 25-OHvitamin D 3 can be further activated to form 1a, 25-dihydroxyvitamin D 3 (calcitriol) by 1a-hydroxylase (CYP27B1), which takes place mainly in the kidney [1, 3, 5] . 25-OH-Vitamin D 3 has been shown to be a major circulating form of vitamin D 3 , and the blood level of 25-OH-vitamin D 3 has been used as a marker of the vitamin D 3 status [6, 7] . Interestingly, 3-O-sulfated form of 25-OH-Vitamin D 3 (25-OH-vitamin D 3 3-O-sulfate) has been detected in human samples at similar or greater levels (ranging 10-50 nM in plasma) than unconjugated 25-OH-vitamin D 3 [8] [9] [10] . Compared with that in adult plasma, a greater proportion of 25-OH-vitamin D 3 3-O-sulfate (more than three times of the concentration of 25-OH-vitamin D 3 ) has been reported to be present in infant plasma, implying the importance of sulfation in the metabolism of vitamin D 3 in infants [11] . It has been proposed that, much like estrone 3-O-sulfate being a storage form of estrone [10] [11] [12] [10, 13] . While it is possible that sulfation may play an important role in the homeostasis of vitamin D 3 , the mechanism underlying the formation of sulfated vitamin D 3 -related compounds has remained unknown [8] .
Sulfation of low-molecular weight compounds is known to be catalyzed by the cytosolic sulfotransferases (SULTs) that mediate the transfer of a sulfonate group from the active sulfate, 3
0 -phosphoadenosine 5 0 -phosphosulfate (PAPS) to substrate compounds [14, 15] . SULT-mediated sulfation is involved in the homeostasis of key endogenous compounds such as steroid and thyroid hormones, as well as the detoxification of a wide range of xenobiotics including drugs [16] [17] [18] . In humans, 13 SULT isoforms that fall into four families have been identified [19, 20] . While numerous studies have revealed a good number of endogenous substrates for the SULT enzymes [20, 21] , whether any of these enzymes may utilize vitamin D 3 ]sulfate using the bifunctional human ATP sulfurylase/APS kinase and its purity determined as previously described [22] . Human kidney, liver, lung, and small intestine cytosol and skin S9 fractions were from XenoTech (Lenexa, KS, USA 
Materials and methods

Preparation of recombinant human SULT enzymes
Thirteen recombinant human SULTs (SULT1A1, SULT1A2, SULT1A3, SULT1B1, SULT1C2, SULT1C3a, SULT1C3d, SULT1C4, SULT1E1, SULT2A1, SULT2B1a, SULT2B1b, and SULT4A1) were expressed in BL21 (DE3) Escherichia coli cells using pGEX-2T, pET23c, or pMALc5x expression system and purified as previously described [23] [24] [25] [26] . The purity of the recombinant enzymes was confirmed by SDS/PAGE based on the method of Laemmli [27] , and the protein concentration was determination based on the method of Bradford [28] with bovine serum albumin as the standard.
Enzymatic assay
The sulfating activity of purified recombinant human SULTs toward vitamin D 3 -related compounds was assayed using radioactive [ .0, 11.5), instead of 50 mM HEPES (pH 7.5), were used in the reactions. For the kinetic studies, varying concentrations of respective substrates and 50 mM HEPES buffer at pH 7.5 were used, and the reactions were carried out under the same conditions as described above. Data obtained were analyzed by EadieHofstee plots and the subsequent nonlinear regression analysis was carried out based on Michaelis-Menten kinetics or sigmoidal kinetics using GRAPHPAD PRISM5 software (GraphPad Software, Inc., La Jolla, CA, USA). For the assays using human organ cytosols, the reaction was performed under above-mentioned assay conditions with 50 mM HEPES buffer at pH 7.5 and a 30 min reaction time, followed by the TLC analysis as described above.
Results
Sulfation of vitamin D 3 -related compounds by human organ samples
Cytosols prepared from major human organs were tested in the enzymatic assay to examine the presence of sulfating activity toward vitamin D 3 -related compounds. Of the five human organ cytosols tested, liver and small intestine cytosols showed stronger sulfating activity than the other three toward all substrates tested ( (Table 2) . Notably, the vitamin D 3 -sulfating activity of SULT2A1 was much lower than the activities toward other substrates. In contrast, SULT1A1 showed sulfating activity toward only calcitriol, whereas SULT2B1a and SULT2B1b showed sulfating activity only with 7-dehydrocholsterol. All other SULTs showed no activity toward any of the vitamin D 3 -related compounds tested.
pH-dependence and kinetic analyses of the enzymatic sulfation of vitamin D 3 -related compounds
The pH-dependence and kinetic parameters of the sulfation of vitamin D 3 -related compounds were analyzed using relevant human SULTs, including SULT1A1, SULT2A1, SULT2B1a, and SULT2B1b. As shown in Fig. 1 , SULT2A1 displayed similar pH-dependence profiles for all four substrates tested, being active over a pH range spanning 7.5-10 and with a peak activity detected at pH 8.5-9.0. SULT2A1 exhibited the Michaelis-Menten kinetics for the sulfation of 7-dehydrocholesterol and vitamin D 3 and the sigmoidal kinetics for the sulfation of 25-OH-vitamin D 3 and calcitriol (Fig. 2) . On the other hand, SULT1A1, SULT2B1a, and SULT2B1b displayed the sigmoidal kinetics for the sulfation of calcitriol and 7-dehydrocholesterol, respectively (data not shown). The kinetic parameters for the sulfation of vitamin D 3 -related compounds by relevant SULTs were calculated based on the kinetic mechanisms determined ( 
Discussion
An increasing body of research findings has implicated sulfation as an important pathway involved in the metabolism of vitamin D 3 -related compounds [8] [9] [10] [11] . No information, however, is currently available concerning the enzymatic mechanisms underlying the sulfation of these important biomolecules. The present study aimed to bridge this significant gap by identifying the responsible SULT enzymes and characterizing the properties of these enzymes in mediating the sulfation of vitamin D 3 -related compounds. Based on the results derived from this study, the sulfation pathway in the metabolism of vitamin D 3 -related compounds can be proposed as depicted in Fig. 3 . 7-Dehydrocholesterol is a biosynthetic precursor of vitamin D 3 in the skin [1, 3, 5] . A previous study has demonstrated that 7-dehydrocholesterol 3-O-sulfate can be converted to vitamin D 3 3-O-sulfate in the skin [13] . While the skin cytosol tested in the present study showed significant 7-dehydrocholesterol-sulfating activity, the activity was much lower than those detected for the cytosols of liver and small intestine (Table 1) . Therefore, 7-dehydrocholesterol 3-O-sulfate may be produced de novo not only in the skin but also in liver and small intestine. It is possible that the bulk of 7-dehydrocholesterol 3-O-sulfate circulating in blood may be produced in the liver and small intestine. The enzymes responsible for the sulfation of the 7-dehydrocholesterol were identified to be SULT2A1 and SULT2B1b based on the enzymatic assay (Tables 1  and 2 ). In the skin, SULT2B1b may play a major role in the sulfation of 7-dehydrocholesterol due to its lower K m value and the lack of SULT2A1 expression [30, 31] . In the liver and small intestine, SULT2A1 is likely the enzyme responsible for the sulfation of 7-dehydrocholesterol due to its strong expression in these two organs [30, 32] . Whether the circulating 7-dehydrocholesterol 3-O-sulfate produced from the liver and small intestine may indeed be converted to vitamin D 3 3-O-sulfate still awaits further investigation. A previous study has shown that vitamin D 3 3-O-sulfate, transformed from 7-dehydrocholesterol 3-O-sulfate in the skin, may be further metabolized to form 25-OHvitamin D 3 3-O-sulfate in the liver [13] . It is noted, however, that 25-OH-vitamin D 3 could also be sulfated by liver and small intestine cytosols at nearly the same level as 7-dehydrocholesterol (Table 1 ). In contrast, vitamin D 3 was sulfated to a much lower extent by liver and small intestine cytosols. The main pathway leading to the production of 25-OH-vitamin D 3 , under standard assay conditions as described in Materials and methods. The curves fitted to the data were generated using Michaelis-Menten or sigmoidal kinetics. The data are calculated mean AE SD derived from three experiments. Table 3 . Kinetic constant of the sulfation of vitamin D3-related compounds by and the relevant human SULTs a . D 3 (calcitriol), an active form of vitamin D 3 produced mainly in the kidney, could also be sulfated by all five organ cytosols with liver and small intestine cytosols displaying the strongest activities. Although there is currently no report showing the presence of sulfated calcitriol in vivo, such a sulfation pathway, if confirmed, may play a role in regulating the physiological activity of calcitriol. SULT2A1, a hydroxysteroid sulfotransferase, has been shown to be capable of catalyzing the sulfation of 3a-hydroxyl, 3b-hydroxyl, or hydroxyl group of the side chains of sterol/steroid compounds [33, 34] . In contrast, SULT2B1b, also called the cholesterol sulfotransferase, has been reported to mediate the sulfation of 3b-hydroxyl group of sterol/steroid compounds [34, 35] . With regard to their constituent hydroxyl groups, 7-dehydrocholesterol carries a 3b-hydroxyl group and the other three vitamin D 3 -related compounds carry a 3a-hydroxhyl group. The differential sulfating activities of SULT2A1 and SULT2B1s toward different vitamin D 3 -related compound are, therefore, in line with previously reported findings, even though vitamin D 3 and its downstream metabolites possess no typical steroid structures. It should be pointed out that SULT2A1 appeared less efficient in sulfating vitamin D 3 in comparison with 25-OH-vitamin D 3 (Tables 2 and 3) . Although the pH profile of the sulfation of all four vitamin D 3 -related compounds tested appeared to be similar (Fig. 1) , kinetic analyses revealed distinct kinetic mechanisms and the associated kinetic parameters for these compounds (Fig. 2) . The kinetics of the sulfation of 25-OH-vitamin D 3 was notably different from that of the sulfation of vitamin D 3 , implying that the 25-hydroxyl group may play an important role in the interaction of 25-OH-vitamin D 3 with the active site of SULT2A1. Previous studies have demonstrated that SULT2A1 exhibited substrate inhibition kinetics in the sulfation of DHEA, a prototype substrate for SULT2A1 [36, 37] , whereas the sulfation of other substrates such as bile acid and oxysterols by SULT2A1 or SULT2B1s appeared to follow Michaelis-Menten kinetics [35, 38, 39] . A binding assay study revealed a negative cooperativity in the binding of DHEA to SULT2A1, indicating the presence of two binding sites for DHEA [37] . Interestingly, celecoxib has been shown to steer SULT2A1-mediated sulfation from the 3-OH to 17-OH group of steroid substrates [40] [41] [42] . A docking simulation study indicated that celecoxib may allosterically dock into the active site of SULT2A1 together with the substrate, thereby altering the conformation of the substrate [42] . It is possible that for 25-OH-vitamin D 3 or calcitriol, two molecules of these substrates may bind to the active site of SULT2A1, with one binding to an allosteric site thereby assisting the other to take on a catalytically favorable orientation, and thus the sigmoidal kinetics for their sulfation.
An important issue is with regard to the functional relevance of the sulfation of the vitamin D 3 -related compounds. SULT-mediated sulfation is generally known to lead to the inactivation and/or the facilitated excretion of substrate compounds from the body [16] [17] [18] . Studies have shown that the sulfation of estrone forming estrone 3-O-sulfate, a main circulating form of estrone, plays an important role in the homeostasis of estrone [12, 43] . As an inactive form of estrone, estrone 3-O-sulfate serves as a precursor of estrone, and can be converted to estrone in target cells under the action of steroid sulfatase [12, 43] . It is possible that 25-OH-vitamin D 3 Author contribution KK, YS, MS, and MCL participated in research design. KK conducted experiments and performed data analysis. KK, YS, MS, and MCL wrote or contributed to the writing of the manuscript.
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